Can neuronal-surface autoantibodies disrupt receptor or ion-channel function without irreversible neuronal destruction?

Neuronal-surface autoimmunity provides a well-supported model in which antibodies cause neurologic dysfunction by changing membrane-protein function and synaptic signaling, rather than requiring immediate irreversible neuronal loss.

Clinical and functional evidence

• CASPR2-IgG can disrupt CASPR2–contactin-2/TAG-1 interactions, mislocalizing Kv1.1/Kv1.2 potassium channels and suppressing repolarizing currents. Impaired afterhyperpolarization and repetitive-firing control provides a direct route to neuronal hyperexcitability.
• Glycine receptor (GlyR) antibodies reduce glycine potency, alter receptor desensitization, suppress glycinergic currents, and can promote receptor internalization.
• GABA_A-receptor antibodies reduce synaptic and extrasynaptic receptor density and inhibitory transmission; direct antagonistic effects are also supported. Together, these mechanisms weaken inhibitory restraint and shift neural networks toward excessive excitability.

Mechanistic implications

• Antibody-induced receptor redistribution/internalization reduces surface availability of GlyR and GABA_A receptors, disrupting inhibitory neurotransmission without needing cell death.
• Alterations in Kv1 channel localization or current impair intrinsic membrane excitability control. Thus, pathogenic effects can arise from disturbed receptor density, ligand responsiveness, channel gating/current, or protein organization at the neuronal surface.

Reversibility and clinical interpretation

• Patient IgG has produced reversible electrophysiologic and memory abnormalities without destructive or pro-inflammatory neuronal injury; improvement after antibody removal or replacement with control serum supports a directly functional mechanism.
• This functional reversibility does not exclude later structural injury: prolonged severe inflammation, sustained seizures, or other downstream complications may ultimately cause neuronal death or atrophy. Mechanistic strength is greatest for CASPR2 and GlyR; GABA_A-receptor findings are supportive but less uniform across studies.

Bottom line

• Pathogenic neuronal-surface autoantibodies can directly disrupt receptor or ion-channel function and neural signaling without irreversible neuronal destruction being required for the initial dysfunction.